🌬️ Smoking Cessation Lung Function Recovery Timeline Simulator

Accelerated FEV1 Decline While Smoking

Smoking roughly doubles the yearly loss of lung function.

• ~30 mL/yr: Normal aging decline (non-smoker after age 25)
• ~60+ mL/yr: Heavy smoker decline (accelerated slope)
• Forced volume, 1 sec: FEV1 (core spirometry metric)
• Rate only: Reversibility (lost volume is not regained)

Why the slope steepens

Chronic inflammation scars small airways year after year.

Every extra pack-year steepens the decline slope further.

What FEV1 measures

Air forcefully exhaled in one second, in milliliters.

The long horizon

Decades of accelerated loss compound toward disability.

The Moment the Slope Begins to Bend

Quitting does not restore lost volume, only the future rate.

• Unchanged: Rate at quit day (still elevated on day one)
• Hours: Biological response (inflammation starts easing)
• Permanent: Volume already lost (not regained by quitting)
• Bends forward: Trajectory (not backward)

A turning point, not a cure

The curve starts to bend, but past losses remain.

The gap between trajectories only opens after this day.

Early airway response

Cilia and mucus clearance begin recovering within days.

Why timing matters

Quitting earlier preserves more lifetime lung function.

Decline Rate Falls Toward Normal

Most of the rate improvement happens within the first year.

• ~40 mL/yr: Rate at 1 year (typical mid-transition value)
• Markedly reduced: Inflammation (vs active smoking)
• Improving: Cough & sputum (common early symptom relief)
• Resets the slope: Relapse risk (restarts accelerated decline)

A steep early correction

The rate drops fastest in the first twelve months.

Sustained abstinence is what locks in the new slope.

Symptom trends

Breathlessness and cough often ease noticeably by year one.

Why relapse resets progress

Resuming smoking re-steepens the decline slope again.

Approaching the Normal Aging Rate

By five years, decline rate nears a non-smoker's pace.

• ~30-33 mL/yr: Rate at 5 years (close to normal aging)
• Widening: Gap vs continued smoking (years of preserved function)
• Partial: Airway remodeling (some structural change persists)
• Falling: Risk trend (lung disease risk keeps dropping)

Convergence with normal aging

The quit-line slope nearly matches the reference line.

Rate normalizes long before any lost volume returns.

What still differs

Baseline FEV1 stays below a lifelong non-smoker's level.

Cumulative benefit

Each year off cigarettes adds preserved lung function.

Two Trajectories Diverging Over Decades

The gap between quitting and continuing widens every year.

• 0-20 yrs: Divergence window (slider-controlled range)
• Higher if quit: Projected FEV1 @70 (vs continued smoking)
• Pack-years: Independent lever (sets starting deficit)
• Earlier is better: Message (but any quit date helps)

Reading the divergence

Two lines from one history split at the quit marker.

The shaded gap is function preserved by quitting.

Pack-years as starting deficit

Heavier smoking history steepens the pre-quit slope.

The takeaway

Quitting sooner and staying quit maximizes preserved lung function.